Release of contraceptive steroids from sustained release dosage forms and resulting plasma levels.
The correlations of plasma levels of levonorgestrel, megestrol acetate and norgestrienone with the doses delivered from subdermal implants and contraceptive rings have been examined. Differences in plasma levels as large as three-fold between different subjects receiving nearly identical doses were observed with all three steroids. The relative plasma levels seen from one subject to another showed high consistency over time. Part of the explanation may lie in differing levels of sex hormone binding globulin, but additional factors must be operative since megestrol acetate binds only weakly with this carrier.
D003274:Contraceptive Devices, Female; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D008535:Megestrol / Q000008:administration & dosage* / Q000097:blood; D009644:Norgestrel / Q000008:administration & dosage* / Q000097:blood; D009645:Norgestrienone / Q000008:administration & dosage* / Q000097:blood; D009651:Norpregnatrienes / Q000008:administration & dosage*; D013997:Time Factors
D009651:Norpregnatrienes; D009644:Norgestrel; D009645:Norgestrienone; D008535:Megestrol